Medical Disclaimer
This website is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication or supplement. Dosage information reflects published FDA-approved labeling or publicly available clinical trial data — individual treatment decisions must be made by a licensed physician.
About Nicotinamide Adenine Dinucleotide (NAD+)
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme used in compounded injectable and IV therapies for energy, cellular health, and anti-aging purposes. It is not FDA-approved as a drug. This page provides reference information on doses used in wellness and functional medicine contexts.
Indication
Wellness/functional medicine use. NOT FDA-approved. Not a GLP-1 medication. Consult a licensed provider.
Research / Trial Dosing Reference
Dosing data from published clinical trials. Not an approved prescription protocol.
| Week / Phase | Dose | At 2.5 mg/mL | At 5 mg/mL | Notes |
|---|---|---|---|---|
| Subcutaneous low dose | 50 mg | 10 units (50 mg/mL) | 5 units (100 mg/mL) | Conservative subcutaneous starting dose. Often used daily. |
| Subcutaneous standard dose | 100 mg | 20 units (50 mg/mL) | 10 units (100 mg/mL) | Common subcutaneous maintenance dose. |
| IV low dose | 250 mg | 250 units (100 mg/mL) | — | Lower IV infusion dose. Must be run slowly (>1–2 hours) to prevent flushing and chest tightness. |
| IV standard dose | 500 mg | 500 units (100 mg/mL) | — | Standard IV infusion dose. Run over 3–4 hours minimum. |
| IV high dose | 1000 mg | 1000 units (100 mg/mL) | — | High IV dose used in some anti-aging protocols. Run over 6–8 hours. |
Units shown assume a standard U-100 insulin syringe (100 units = 1 mL). Always confirm your vial concentration with your pharmacy.
Dose Calculator
Enter your prescribed dose and vial concentration to calculate how many units to draw.
mg ↔ Units Dose Calculator
Convert between milligrams and insulin-syringe units for compounded GLP-1 medications. Uses a standard U-100 syringe (100 units = 1 mL).
2.5 mg at 2.5 mg/mL → 1.000 mL → 100 units on a U-100 (100-unit / 1 mL) insulin syringe
Always verify calculations with your prescribing provider or pharmacist before administering any medication. This calculator is for reference only.
Injection Sites
Subcutaneous (abdomen)
SubQ injection into abdominal fatty tissue for at-home protocols.
- Use a 29–31 gauge needle
- Rotate sites daily
- Burning sensation is common — inject slowly
IV (peripheral vein)
Intravenous infusion typically administered in a clinic.
- Must be administered by trained personnel
- Run slowly to minimize flushing, chest tightness, and nausea
- Side effects are rate-dependent — slow the drip if symptoms occur
Storage Instructions
- Refrigerate compounded NAD+ solutions
- Protect from light — use amber vials
- Check expiration with compounding pharmacy
- Do not freeze IV solutions
Common Side Effects
Contact your healthcare provider if side effects are severe or persistent.
- IV: Flushing, chest tightness, nausea, headache (rate-dependent — slow the infusion)
- SubQ: Injection site burning, itching
- Fatigue or energy surge (paradoxical response possible initially)
Frequently Asked Questions
What is NAD+ used for?
How much NAD+ should I take?
Can I do NAD+ injections at home?
Primary Source
FDA / Clinical Source
Dosing information sourced from: https://www.fda.gov/drugs/human-drug-compounding
Related Guides
Retatrutide Dosage Chart
(Investigational — LY3437943)
Retatrutide dosage overview — clinical trial dosing data
Cagrilintide Dosage Chart
CagriSema (combination with semaglutide — investigational)
Cagrilintide dosage — amylin analogue overview
BPC-157 Dosage Chart
Research peptide — not FDA-approved
BPC-157 dosage reference — research peptide guide